These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15110977)

  • 1. Antibacterial agents for ocular therapeutics.
    Kern TJ
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):655-68. PubMed ID: 15110977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primer on topical antibiotics for the skin and eyes.
    Noah S
    J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of common ophthalmic antibacterial and corticosteroid-antibacterial combination drugs.
    Thomas RK; Melton NR
    Optom Clin; 1992; 2(4):45-57. PubMed ID: 1286240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ocular bacterial infections: an update.
    Hammond RW; Edmondson W
    J Am Optom Assoc; 1997 Mar; 68(3):178-87. PubMed ID: 9109296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigations on chloramphenicol availability in ophthalmic lamellae].
    Gafitanu E; Zvorişteanu V; Matei I; Braha S; Dorneanu V; Awe B
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(3):519-23. PubMed ID: 16296483
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
    Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).
    Schlech BA; Blondeau J
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S64-7. PubMed ID: 16257312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of corticosteroids to treat ocular inflammation.
    Holmberg BJ; Maggs DJ
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):693-705. PubMed ID: 15110979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of Listeria monocytogenes keratitis to respond to topical ofloxacin.
    Altaie R; Fahy GT; Cormican M
    Cornea; 2006 Aug; 25(7):849-50. PubMed ID: 17068464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical chloramphenicol for eye infections.
    Lam RF; Lai JS; Ng JS; Rao SK; Law RW; Lam DS
    Hong Kong Med J; 2002 Feb; 8(1):44-7. PubMed ID: 11861993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular bacterial infections: current and future treatment options.
    Kowalski RP; Dhaliwal DK
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):131-9. PubMed ID: 15757463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy of acute bacterial infections of the eye].
    Bialasiewicz AA
    Fortschr Ophthalmol; 1990; 87 Suppl():S82-93. PubMed ID: 2083916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness.
    Veldman P; Colby K
    Int Ophthalmol Clin; 2011; 51(4):43-52. PubMed ID: 21897139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bioavailability of antibiotics].
    Robert PY; Tassy A
    J Fr Ophtalmol; 2000 May; 23(5):510-3; quiz 523. PubMed ID: 10844315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal staining after treatment with topical tetracycline.
    Lapid-Gortzak R; Nieuwendaal CP; Slomovic AR; Spanjaard L
    Cornea; 2006 Sep; 25(8):969-70. PubMed ID: 17102677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of moxifloxacin as shown in animal and in vitro studies.
    McGee DH; Holt WF; Kastner PR; Rice RL
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S46-54. PubMed ID: 16257310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungals and their use in veterinary ophthalmology.
    Ford MM
    Vet Clin North Am Small Anim Pract; 2004 May; 34(3):669-91. PubMed ID: 15110978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
    Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbial colonization of ocular prosthesis].
    Murariu L
    Bacteriol Virusol Parazitol Epidemiol; 2005; 50(1-2):35-40. PubMed ID: 17300029
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors.
    O'Brien TP
    Eye (Lond); 2003 Nov; 17(8):957-74. PubMed ID: 14631403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.